See Tai Sandi, Chief Development Officer at Lexeo Therapeutics, Inc. ($LXEO), made five open market sales of common shares in the last 365 days, totaling $41,146. His most recent sale was on November 18, 2025. These Lexeo Therapeutics insider sales rank 10,579th among 11,678 individual insiders by sale amount, well below the average of $8.6 million across 6.4 transactions. See Tai Sandi reported no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 18, 2025 | Lexeo Therapeutics, Inc. | $LXEO | See Tai Sandi | Chief Development Officer | S | Common Stock | 386 | $9.27 | 65,476.0000 | 72,987,327 | 0.59% | 0.00% |
| Oct. 15, 2025 | Lexeo Therapeutics, Inc. | $LXEO | See Tai Sandi | Chief Development Officer | A | Common Stock | 10890 | $0.00 | 69,750.0000 | 33,196,997 | 18.50% | 0.03% |
| Oct. 17, 2025 | Lexeo Therapeutics, Inc. | $LXEO | See Tai Sandi | Chief Development Officer | S | Common Stock | 44 | $9.56 | 65,862.0000 | 33,196,997 | 0.07% | 0.00% |
| Oct. 17, 2025 | Lexeo Therapeutics, Inc. | $LXEO | See Tai Sandi | Chief Development Officer | S | Common Stock | 3844 | $8.94 | 65,906.0000 | 33,196,997 | 5.51% | 0.01% |
| Aug. 18, 2025 | Lexeo Therapeutics, Inc. | $LXEO | See Tai Sandi | Chief Development Officer | S | Common Stock | 382 | $4.67 | 58,860.0000 | 33,196,997 | 0.64% | 0.00% |
| May 16, 2025 | Lexeo Therapeutics, Inc. | $LXEO | See Tai Sandi | Chief Development Officer | S | Common Stock | 367 | $2.77 | 59,242.0000 | 33,196,997 | 0.62% | 0.00% |
| March 14, 2025 | Lexeo Therapeutics, Inc. | $LXEO | See Tai Sandi | Chief Development Officer | A | Common Stock | 5720 | $2.61 | 59,609.0000 | 0 | 10.61% | 0.00% |
| Feb. 19, 2025 | Lexeo Therapeutics, Inc. | $LXEO | See Tai Sandi | Chief Development Officer | S | Common Stock | 1486 | $4.41 | 53,889.0000 | 0 | 2.68% | 0.00% |
| Jan. 7, 2025 | Lexeo Therapeutics, Inc. | $LXEO | See Tai Sandi | Chief Development Officer | A | Stock Option (right to buy) | 77500 | $0.00 | 77,500.0000 | 0 | 9999.99% | 0.00% |
| Jan. 7, 2025 | Lexeo Therapeutics, Inc. | $LXEO | See Tai Sandi | Chief Development Officer | A | Common Stock | 38750 | $0.00 | 55,375.0000 | 0 | 233.08% | 0.00% |